Uppdrag

Vinge biträdde Carnegie och Kempen & Co i BioInvents riktade nyemission

9 juni 2011

BioInvent International AB (publ) (NASDAQ OMX Stockholm) har genomfört en riktad nyemission till internationella institutionella investerare och kvalificerade investerare i Sverige genom ett bookbuilding-förfarande. Carnegie Investment Bank och Kempen & Co var Joint Global Co-ordinators och Joint Bookrunners i transaktionen.

Vinge och Latham & Watkins biträdde Carnegie och Kempen & Co. Vinges team bestod av Erik Sjöman och Christian Lindhé.

Wibeke Sorling utnämnd till ny delägare

Med start 1 januari 2022 tillträder Wibeke Sorling som delägare på Vinges Göteborgskontor.
27 oktober 2021

Arbitration proceedings between a Member State and an investor from another Member State further curtailed – the judgment of the EU Court of Justice in PL Holdings

Following the much debated judgment by the CJEU in Achmea, arbitration clauses in bilateral investment treaties between Member States under which an investor in one of those Member States may bring proceedings against the other Member State are considered incompatible with EU law. However, the judgment in Achmea seemed to leave it open whether an arbitration agreement between a Member State and an investor from another Member State not based on such a clause would be considered acceptable by the CJEU. Yesterday’s ruling by the Court in the Swedish case PL Holdings (Case C-109/20) dealt with one aspect of this question, resulting in further limits to investment arbitration in the EU.
27 oktober 2021

Vinge slår upp portarna till IP@Vinge

Den 6 december bjuder vi in till IP@Vinge, en förmiddag i immaterialrättens tecken som samlar några av Sveriges främsta experter på IP-området. Tillsammans med inbjudna gäster diskuterar vi ett antal högaktuella IP-frågor under ledning av jur. dr Ulrika Wennersten.
22 oktober 2021